The “2022 Glaucoma Pharmaceuticals Market Report” provides updated analysis of the global and regional prevalence of glaucoma and the latest breakdown of diagnosis and treatment paradigms.
The report features new sales forecasts, an updated analysis of the glaucoma pharmaceuticals pipeline, new market share data of generics, updated shares of patients by primary glaucoma medicine, specialty share of US prescribing doctors, and survey data on US ophthalmologists preferences for sustained drug delivery.
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.